Reply to "Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy"

Thomas Stranzl, Henrik Ipsen, Lars Harder Christensen, Thomas Eiwegger, Niels Johansen, Kaare Lund, Peter Sejr Andersen

Research output: Journal article (peer-reviewed)Letter/short communication

Original languageEnglish
Pages (from-to)1300-1301
Number of pages2
JournalAllergy: European Journal of Allergy and Clinical Immunology
Issue number4
Publication statusPublished - Apr 2021
Externally publishedYes


  • Humans
  • Hypersensitivity
  • Immunoglobulin E
  • Sublingual Immunotherapy
  • Tablets
  • Treatment Outcome

Cite this